Abdul, Joaisa S.
HRN: 25-47-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2024
LEVOFLOXACIN 500MG (TAB)
07/11/2024
07/18/2024
IV
500mg
Once Daily
Acute Pyelonephritis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes